In conclusion, our data support the role of lactate metabolism in breast cancer, highlighting a new pathway activated by glucose metabolism in the tumor microenvironment, i.e., the activation of GPR81/IGFBP6 crosstalk (Figure 6), which may represent a new therapeutic target in breast cancer. This evidence concerns the gene HCAR1 and neoplasm.